NCT07219173
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT07219173
- Registry
- ClinicalTrials.gov
- NCT number
- NCT07219173
- Sponsor, as registered
- Eli Lilly and Company
- Phase
- PHASE2
- Indication
- Asthma
- Status
- RECRUITING
- Start date
- 2025-10-22
- Primary completion
- 2028-04
- Registered countries
- Argentina, Brazil, Canada, China, France, Germany, India, Japan, Mexico, Netherlands, Poland, United States
- Sites
- 120
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-11-07
Notes on the record
Supersedes the row verified 2026-10-26 (kept), per DATA LAYER rule 4. Read live from the ClinicalTrials.gov v2 API 2026-11-07 (https://clinicaltrials.gov/api/v2/studies/NCT07219173); record last update posted 2026-11-05. site_count 119 to 120 location entries; status, dates and the twelve countries unchanged. Flagged by the collector (inbox/2026-11-06.json); collector proposal replaced by this live read.
Company
Through brenipatide (LY3537031): Lilly
Cited in
Issues quoting NCT07219173 in their own text.